cardicor 10 mg filmdragerad tablett
merck ab - bisoprololfumarat - filmdragerad tablett - 10 mg - bisoprololfumarat 10 mg aktiv substans - bisoprolol
cardicor 2,5 mg filmdragerad tablett
merck ab - bisoprololfumarat - filmdragerad tablett - 2,5 mg - bisoprololfumarat 2,5 mg aktiv substans - bisoprolol
cardicor 3,75 mg filmdragerad tablett
merck ab - bisoprololfumarat - filmdragerad tablett - 3,75 mg - bisoprololfumarat 3,75 mg aktiv substans - bisoprolol
cardicor 5 mg filmdragerad tablett
merck ab - bisoprololfumarat - filmdragerad tablett - 5 mg - bisoprololfumarat 5 mg aktiv substans - bisoprolol
cardicor 7,5 mg filmdragerad tablett
merck ab - bisoprololfumarat - filmdragerad tablett - 7,5 mg - bisoprololfumarat 7,5 mg aktiv substans - bisoprolol
atostin 10 mg filmdragerad tablett
krka d.d., novo mesto - atorvastatinkalcium, amorft - filmdragerad tablett - 10 mg - natriumlaurilsulfat hjälpämne; atorvastatinkalcium, amorft 10,36 mg aktiv substans; laktosmonohydrat hjälpämne - atorvastatin
atostin 20 mg filmdragerad tablett
krka d.d., novo mesto - atorvastatinkalcium, amorft - filmdragerad tablett - 20 mg - natriumlaurilsulfat hjälpämne; atorvastatinkalcium, amorft 20,72 mg aktiv substans; laktosmonohydrat hjälpämne - atorvastatin
atostin 40 mg filmdragerad tablett
krka d.d., novo mesto - atorvastatinkalcium, amorft - filmdragerad tablett - 40 mg - natriumlaurilsulfat hjälpämne; atorvastatinkalcium, amorft 41,44 mg aktiv substans; laktosmonohydrat hjälpämne - atorvastatin
imatinib viatris 400 mg filmdragerad tablett
viatris limited - imatinibmesilat - filmdragerad tablett - 400 mg - imatinibmesilat 478 mg aktiv substans
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastiska medel - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.